Hangzhou Tigermed Consulting Co Ltd

Chart & Performance

D1W1MN

P/E

43.39

P/S

5.64

EPS

0.73

Div Yield, %

0.94%

Shrs. gr., 5y

1.51%

Rev. gr., 5y

16.44%

Revenues

6.83b

+3.48%

Net income

888m

+119.15%

CFO

1.12b

+1.92%

Dividend

Jun 12, 20250.3245 HKD/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.

URL

https://www.tigermedgrp.com/

IPO date

Aug 17, 2012

Employees

9,455

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT